HIGHLIGHTS
- who: November et al. from the University of Kansas Medical Center, United States have published the research work: Analysis of the safety and ef cacy of different plasma concentrations of pirfenidone in patients with idiopathic pulmonary brosis, in the Journal: (JOURNAL)
- what: In view of this, this study investigates the safety and efficacy of different plasma concentrations of pirfenidone in the treatment of patients with IPF and explores appropriate drug reference for clinical treatment decisions. This study showed no significant differences between the two different concentration groups regarding the changes in the percentage of predicted . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.